Shortly after recommending approval of Qnexa (Phentermine / Topiramate), the FDA advisory panel this week also voted to approve Arena Pharmaceuticals weight loss drug, Lorgess (Lorcacerin). This medication has been in clinical trials over the past several years and works through the 5HT2c sub-type Seratonin receptor in the brain. Why is this important? What is […]
12
May
FDA panel endorses another weight loss drug
Posted In: Medical Weight Loss News By Dr. Lazarus
Tagged : Lorgess, phentermine, qnexa
Comments : 4 responses
